William Hickey Bought 346 Shares of Kingsway Financial Services Inc. (KFS); Retrophin (RTRX) Has 1.13 Sentiment

Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. The company has market cap of $1.00 billion. The Company’s marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in well-opacifying gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for adjunctive treatment of patients with peroxisomal disorders; and Thiola, a tiopronin tablet for the treatment of cystinuria. It currently has negative earnings. The companyÂ’s product candidates consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis; Fosmetpantotenate, a novel small molecule that is in Phase III clinical trial to treat pantothenate kinase-associated neurodegeneration; Tetracosactide Zinc , a synthetic hormone analog that is in preclinical stage; and Liquid Ursodeoxycholic Acid, a liquid formulation of ursodeoxycholic acid, which is in preclinical stage to treat primary biliary cholangitis.

The Kingsway Financial Services Inc’s CFO and EVP William Hickey acquired – 346 shares of Kingsway Financial Services Inc, based on the market stock price per share of $4.3 per each share. The purchased shares had a value of about $1,501 U.S. Dollars. In the last 30 days, he also purchased 570 shares with a total value of about $2,992 USD. Now, William Hickey owns 305,210 shares which are about 1.41% of the company’s total market capitalization. A filing ready for review here discloses this insider activity, that took place on 15-03-2018 and was filed with the Security Exchange Commission.

Investors sentiment increased to 3.5 in 2017 Q3. Its up 2.17, from 1.33 in 2017Q2. It increased, as 0 investors sold Kingsway Financial Services Inc. shares while 3 reduced holdings. 1 funds opened positions while 3 raised stakes. 696,960 shares or 4.43% more from 667,396 shares in 2017Q2 were reported. Deutsche Retail Bank Ag holds 28,078 shares or 0% of its portfolio. Financial Bank Of Montreal Can invested 0% of its portfolio in Kingsway Financial Services Inc. (NYSE:KFS). Css Limited Com Il reported 0.01% stake. Toronto Dominion Fincl Bank has invested 0% of its portfolio in Kingsway Financial Services Inc. (NYSE:KFS). Royal Bancorporation Of Canada holds 0% or 1,138 shares. Bradley Foster & Sargent Ct holds 0.02% or 65,038 shares. The Pennsylvania-based Zeke Capital Advisors Limited Liability Company has invested 0.03% in Kingsway Financial Services Inc. (NYSE:KFS). Raymond James Serv Advsrs Inc holds 0% or 12,400 shares. Gluskin Sheff Associates has invested 0.13% in Kingsway Financial Services Inc. (NYSE:KFS). Missouri-based Stifel Financial has invested 0% in Kingsway Financial Services Inc. (NYSE:KFS). 269,800 are owned by Renaissance. Jpmorgan Chase & Comm holds 0% of its portfolio in Kingsway Financial Services Inc. (NYSE:KFS) for 300 shares. Morgan Stanley has invested 0% in Kingsway Financial Services Inc. (NYSE:KFS).

The stock decreased 1.15% or $0.05 during the last trading session, reaching $4.3. About 30,632 shares traded. Kingsway Financial Services Inc. (NYSE:KFS) has risen 35.78% since March 16, 2017 and is uptrending. It has outperformed by 19.08% the S&P500.

Kingsway Financial Services Inc., through its subsidiaries, provides property and casualty insurance products in the United States. The company has market cap of $93.24 million. The firm operates through three divisions: Insurance Underwriting, Insurance Services, and Leased Real Estate. It currently has negative earnings. The Insurance Underwriting segment offers various automobile insurance products, including liability insurance that covers claims against its insuredÂ’s responsible for automobile accidents; accident benefit policies or personal injury protection policies that provide coverage for loss of income, medical, and rehabilitation expenses for insured persons who are injured in an automobile accident; and physical damage policies, which cover damages to an insured automobile arising from a collision with another object, as well as from other risks, such as fire or theft.

Since December 12, 2017, it had 25 insider purchases, and 1 sale for $146,221 activity. BAQAR HASSAN had bought 176 shares worth $1,002. Kavanagh Terence Michael bought $151,500 worth of Kingsway Financial Services Inc. (NYSE:KFS) on Tuesday, December 12. Hickey William August Jr bought $1,504 worth of stock. STILWELL JOSEPH also bought $50,222 worth of Kingsway Financial Services Inc. (NYSE:KFS) shares. $1,672 worth of Kingsway Financial Services Inc. (NYSE:KFS) was bought by Fitzgerald John Taylor Maloney. 427 shares were bought by SWETS LARRY G JR, worth $2,082 on Thursday, March 1. $39,184 worth of Kingsway Financial Services Inc. (NYSE:KFS) was bought by Schaevitz Gary.

The stock decreased 0.40% or $0.1 during the last trading session, reaching $25.21. About 188,244 shares traded. Retrophin, Inc. (RTRX) has risen 4.93% since March 16, 2017 and is uptrending. It has underperformed by 11.77% the S&P500.

Consonance Capital Management Lp holds 9.65% of its portfolio in Retrophin, Inc. for 3.51 million shares. Broadfin Capital Llc owns 1.72 million shares or 6.32% of their US portfolio. Moreover, Perceptive Advisors Llc has 2.55% invested in the company for 2.69 million shares. The Georgia-based Emory University has invested 1.46% in the stock. Oak Ridge Investments Llc, a Illinois-based fund reported 739,462 shares.

Since January 1, 0001, it had 0 insider purchases, and 2 sales for $44,878 activity.

Analysts await Retrophin, Inc. (NASDAQ:RTRX) to report earnings on May, 3. They expect $-0.63 EPS, down 6,400.00% or $0.64 from last year’s $0.01 per share. After $-0.39 actual EPS reported by Retrophin, Inc. for the previous quarter, Wall Street now forecasts 61.54% negative EPS growth.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter:



 

Recent Posts